Time to revisit role of transcatheter balloon aortic valvuloplasty: A bridge-therapy to subsequent treatment case report

Akira Furuta, Hideyuki Shimizu, Takashi Hachiya, Yohei Ohno, Hiroyuki Kawajiri, Akio Kawamura, Kiyokazu Kokaji, Ryohei Yozu, Keiichi Fukuda

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Recently there has been a noticeable resurgence in the usage of percutaneous balloon aortic valvuloplasty (BAV) by the development of less invasive endovascular therapies including transcatheter aortic valve implantation (TAVI). We performed BAV in a 91-year-old man with end-stage severe symptomatic aortic stenosis (AS) and an impending abdominal aortic aneurysm (AAA) rupture who had been refused surgical treatment because of the comorbidities with stage V chronic kidney disease (CKD) and severe left ventricular dysfunction. Improvement in hemodynamics and kidney function was observed after BAV. Subsequently, we performed endovascular aneurysm repair (EVAR) successfully for AAA using iodinated contrast. No deterioration of kidney function was confirmed after the procedure. The patient was discharged without any adverse events. At present, the possibilities of TAVI or surgical aortic valve replacement (s-AVR) are under consideration as the definitive therapy for the upcoming aortic valve restenosis. In conclusion, this inoperable patient with multiple comorbidities was successfully treated, at lower risk, by catheter-based two-stage therapy.

Original languageEnglish
Pages (from-to)397-400
Number of pages4
JournalHeart and Vessels
Volume28
Issue number3
DOIs
Publication statusPublished - 2013 May

Fingerprint

Balloon Valvuloplasty
Abdominal Aortic Aneurysm
Aortic Valve
Comorbidity
Kidney
Aortic Rupture
Aortic Valve Stenosis
Left Ventricular Dysfunction
Therapeutics
Chronic Renal Insufficiency
Surgical Instruments
Aneurysm
Catheters
Hemodynamics
Transcatheter Aortic Valve Replacement

Keywords

  • Aortic aneurysm
  • Aortic stenosis
  • Chronic kidney disease
  • Valvuloplasty
  • Vascular disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Time to revisit role of transcatheter balloon aortic valvuloplasty : A bridge-therapy to subsequent treatment case report. / Furuta, Akira; Shimizu, Hideyuki; Hachiya, Takashi; Ohno, Yohei; Kawajiri, Hiroyuki; Kawamura, Akio; Kokaji, Kiyokazu; Yozu, Ryohei; Fukuda, Keiichi.

In: Heart and Vessels, Vol. 28, No. 3, 05.2013, p. 397-400.

Research output: Contribution to journalArticle

Furuta, Akira ; Shimizu, Hideyuki ; Hachiya, Takashi ; Ohno, Yohei ; Kawajiri, Hiroyuki ; Kawamura, Akio ; Kokaji, Kiyokazu ; Yozu, Ryohei ; Fukuda, Keiichi. / Time to revisit role of transcatheter balloon aortic valvuloplasty : A bridge-therapy to subsequent treatment case report. In: Heart and Vessels. 2013 ; Vol. 28, No. 3. pp. 397-400.
@article{798b71c1bb8342bd81bbba8c768cfc75,
title = "Time to revisit role of transcatheter balloon aortic valvuloplasty: A bridge-therapy to subsequent treatment case report",
abstract = "Recently there has been a noticeable resurgence in the usage of percutaneous balloon aortic valvuloplasty (BAV) by the development of less invasive endovascular therapies including transcatheter aortic valve implantation (TAVI). We performed BAV in a 91-year-old man with end-stage severe symptomatic aortic stenosis (AS) and an impending abdominal aortic aneurysm (AAA) rupture who had been refused surgical treatment because of the comorbidities with stage V chronic kidney disease (CKD) and severe left ventricular dysfunction. Improvement in hemodynamics and kidney function was observed after BAV. Subsequently, we performed endovascular aneurysm repair (EVAR) successfully for AAA using iodinated contrast. No deterioration of kidney function was confirmed after the procedure. The patient was discharged without any adverse events. At present, the possibilities of TAVI or surgical aortic valve replacement (s-AVR) are under consideration as the definitive therapy for the upcoming aortic valve restenosis. In conclusion, this inoperable patient with multiple comorbidities was successfully treated, at lower risk, by catheter-based two-stage therapy.",
keywords = "Aortic aneurysm, Aortic stenosis, Chronic kidney disease, Valvuloplasty, Vascular disease",
author = "Akira Furuta and Hideyuki Shimizu and Takashi Hachiya and Yohei Ohno and Hiroyuki Kawajiri and Akio Kawamura and Kiyokazu Kokaji and Ryohei Yozu and Keiichi Fukuda",
year = "2013",
month = "5",
doi = "10.1007/s00380-012-0268-z",
language = "English",
volume = "28",
pages = "397--400",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Time to revisit role of transcatheter balloon aortic valvuloplasty

T2 - A bridge-therapy to subsequent treatment case report

AU - Furuta, Akira

AU - Shimizu, Hideyuki

AU - Hachiya, Takashi

AU - Ohno, Yohei

AU - Kawajiri, Hiroyuki

AU - Kawamura, Akio

AU - Kokaji, Kiyokazu

AU - Yozu, Ryohei

AU - Fukuda, Keiichi

PY - 2013/5

Y1 - 2013/5

N2 - Recently there has been a noticeable resurgence in the usage of percutaneous balloon aortic valvuloplasty (BAV) by the development of less invasive endovascular therapies including transcatheter aortic valve implantation (TAVI). We performed BAV in a 91-year-old man with end-stage severe symptomatic aortic stenosis (AS) and an impending abdominal aortic aneurysm (AAA) rupture who had been refused surgical treatment because of the comorbidities with stage V chronic kidney disease (CKD) and severe left ventricular dysfunction. Improvement in hemodynamics and kidney function was observed after BAV. Subsequently, we performed endovascular aneurysm repair (EVAR) successfully for AAA using iodinated contrast. No deterioration of kidney function was confirmed after the procedure. The patient was discharged without any adverse events. At present, the possibilities of TAVI or surgical aortic valve replacement (s-AVR) are under consideration as the definitive therapy for the upcoming aortic valve restenosis. In conclusion, this inoperable patient with multiple comorbidities was successfully treated, at lower risk, by catheter-based two-stage therapy.

AB - Recently there has been a noticeable resurgence in the usage of percutaneous balloon aortic valvuloplasty (BAV) by the development of less invasive endovascular therapies including transcatheter aortic valve implantation (TAVI). We performed BAV in a 91-year-old man with end-stage severe symptomatic aortic stenosis (AS) and an impending abdominal aortic aneurysm (AAA) rupture who had been refused surgical treatment because of the comorbidities with stage V chronic kidney disease (CKD) and severe left ventricular dysfunction. Improvement in hemodynamics and kidney function was observed after BAV. Subsequently, we performed endovascular aneurysm repair (EVAR) successfully for AAA using iodinated contrast. No deterioration of kidney function was confirmed after the procedure. The patient was discharged without any adverse events. At present, the possibilities of TAVI or surgical aortic valve replacement (s-AVR) are under consideration as the definitive therapy for the upcoming aortic valve restenosis. In conclusion, this inoperable patient with multiple comorbidities was successfully treated, at lower risk, by catheter-based two-stage therapy.

KW - Aortic aneurysm

KW - Aortic stenosis

KW - Chronic kidney disease

KW - Valvuloplasty

KW - Vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84878720342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878720342&partnerID=8YFLogxK

U2 - 10.1007/s00380-012-0268-z

DO - 10.1007/s00380-012-0268-z

M3 - Article

C2 - 22828796

AN - SCOPUS:84878720342

VL - 28

SP - 397

EP - 400

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 3

ER -